Alex Zhavoronkov is the founder and CEO of Insilico Medicine, a biotechnology company that focuses on drug discovery and aging research using artificial intelligence. He is a prominent figure in the field of biomedical research and is known for his expertise in applying AI and machine learning to drug development. Under his leadership, Insilico Medicine has made significant strides in using AI to accelerate the drug discovery process.